This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by González-Juanatey, J. R. Articles by Cabezas-Cerrato, J. Search for Related Content PubMed PubMed Citation Articles by González-Juanatey, J. R. Articles by Cabezas-Cerrato, J.

(Hypertension. 1999;34:1287.)
© 1999 American Heart Association, Inc.

Scientific Contributions

Step-Down of Enalapril Treatment for Arterial Hypertension

José Ramón González-Juanatey; Antonio Pose Reino; José María García-Acuña; Carlos González-Juanatey; Luis Valdes; José Cabezas-Cerrato

From the Cardiology Department, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.

Correspondence to José Ramón González-Juanatey, Cardiology Department, Hospital Xeral de Galicia, Galeras s/n, 15705 Santiago de Compostela, Spain. E-mail jgonzalezd{at}meditex.es

Abstract—Enalapril treatment (20 mg every 12 hours) of 24 patients with essential hypertension and left ventricular (LV) hypertrophy established normal blood pressures after 8 weeks, and after 5 years, it had reduced LV mass index by 39% (from 148±34 to 90±16 g/m²) and had normalized LV structure and function and QT dispersion. Stepwise reduction of the enalapril dosage from 40 to 30, 20, 10, and 5 mg/d during the eighth year caused no significant change in blood pressure, LV structure, LV systolic function, or QT dispersion, which all likewise remained unaltered during an additional 2-year period of the 5-mg/d regimen. We conclude that for hypertensive patients in whom prolonged treatment with high doses of enalapril has normalized blood pressure, LV structure, LV function, and QT dispersion, the dose may be reduced as much as 8-fold without detriment to cardiovascular control. The use of smaller doses is evidently advantageous from the point of view of health costs.

Key Words: hypertension, essential • hypertension, arterial • enalapril